miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

about

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

Item

http://www.wikidata.org/entity/Q50026324

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@en

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@nl

type

Item

label

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@en

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@nl

prefLabel

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@en

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@nl

P1476

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targeting c-Jun.

@en

P2093

Hui Ru-Tai

http://www.w3.org/2001/XMLSchema#string

Jia Mei

http://www.w3.org/2001/XMLSchema#string

Li Jian-Hui

http://www.w3.org/2001/XMLSchema#string

Qiu Wei

http://www.w3.org/2001/XMLSchema#string

Song Lei

http://www.w3.org/2001/XMLSchema#string

Su Ming

http://www.w3.org/2001/XMLSchema#string

Wang Hui

http://www.w3.org/2001/XMLSchema#string

Wang Ji-Zheng

http://www.w3.org/2001/XMLSchema#string

Wang Shui-Yun

http://www.w3.org/2001/XMLSchema#string

P2860

How do MYBPC3 mutations cause hypertrophic cardiomyopathy?

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction

Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress

Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Incorporating structure to predict microRNA targets.

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1.

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.

Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis

MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis.

P31

scholarly article

P356

10.1042/BSR20171430

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29440459

http://www.w3.org/2001/XMLSchema#string

P932

5843750

http://www.w3.org/2001/XMLSchema#string